The predicted share price (Closing Price) for Zota Health Care Ltd for tomorrow (2026-05-09) is ₹905.25 which is 15.00% lower than today’s share price of ₹1,065.00
Zota Health Care Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Overvalued
Intrinsic ₹140.24 vs CMP ₹1,065.00 (-86.8%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
▼ Bearish
Price/EMA: 0.866 · EMA(252): ₹1,230.13
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
65% annualized
Risk: High · Recent trend: Rising (recent > historical)
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Trending (persistent)
Hurst exponent: 0.569
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
-3.6%5Y-1.6%10Y
Historical drift: +23.7% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
-0.89x
Upside -86.8% vs downside 97.2% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
-659.4%
No margin
Model ConfidenceiShows how reliable our predictions are for this stock. Based on the model's average prediction error over the last 90 days. Low error = high confidence. Also shows data coverage — more data points over longer periods produce more reliable projections. The model self-learns by adjusting parameters every 7 days.
Low
Avg error: 17.7% · 494 data points over 624 days
Fundamental FlooriThe lowest price the stock is expected to reach under normal market conditions, based on book value and financial strength (ROE, ROCE, debt ratios). A very low floor relative to CMP means the company has limited tangible asset backing at current prices. In extreme market crashes, prices can temporarily breach this level.
₹30.22
(97.2% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹1,043.00
₹1,687.00
CMP: ₹1,065.003% into range36.9% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows how long the model expects the stock price to take to converge toward its intrinsic value. The model uses a mathematical convergence rate that pulls the projected price toward intrinsic value gradually. Milestones show the expected price at 25%, 50%, 75%, and 100% convergence. For overvalued stocks, convergence means the price may decline toward intrinsic value.
Target: ₹140.24 in ~5.0 years (2031)
Now ₹1,06525% ₹83450% ₹60375% ₹371Target ₹140
Gap: 86.8% downward · Model convergence rate: 5.0 years
What this means: Zota Health Care Ltd appears overvalued by 86.8% relative to intrinsic value. The stock is currently in a bearish regime (price below EMA). A Hurst exponent of 0.57 indicates trending behavior — recent price momentum is likely to persist. Volatility is high (65% annualized), implying wider price swings and higher risk.
Zota Health Care Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
1,010.46
-5.1%
-5.1%
Month
Projected Price (₹)
Jan
1,054.14
Feb
1,039.93
Mar
1,031.58
Apr
1,028.89
May
1,026.82
Jun
1,018.63
Jul
1,030.32
Aug
1,014.98
Sep
1,000.94
Oct
992.67
Nov
999.65
Dec
1,010.46
2028
974.09
-8.5%
-4.4%
Month
Projected Price (₹)
Jan
989.82
Feb
989.85
Mar
986.20
Apr
983.92
May
979.38
Jun
966.62
Jul
948.54
Aug
949.13
Sep
954.84
Oct
956.99
Nov
957.89
Dec
974.09
2029
940.08
-11.7%
-4.1%
Month
Projected Price (₹)
Jan
976.23
Feb
953.50
Mar
957.80
Apr
954.91
May
956.10
Jun
954.47
Jul
953.92
Aug
946.49
Sep
963.05
Oct
966.47
Nov
946.86
Dec
940.08
2030
892.04
-16.2%
-4.3%
Month
Projected Price (₹)
Jan
950.50
Feb
950.76
Mar
935.44
Apr
930.56
May
922.41
Jun
908.51
Jul
902.22
Aug
895.09
Sep
891.15
Oct
888.91
Nov
891.47
Dec
892.04
2031
885.86
-16.8%
-3.6%
Month
Projected Price (₹)
Jan
891.81
Feb
896.40
Mar
885.73
Apr
894.84
May
899.84
Jun
888.44
Jul
874.88
Aug
870.84
Sep
880.04
Oct
882.50
Nov
881.62
Dec
885.86
2032
890.07
-16.4%
-2.9%
Month
Projected Price (₹)
Jan
878.45
Feb
893.93
Mar
890.49
Apr
897.98
May
902.74
Jun
901.32
Jul
892.97
Aug
903.59
Sep
902.81
Oct
909.24
Nov
899.11
Dec
890.07
2033
862.05
-19.1%
-3.0%
Month
Projected Price (₹)
Jan
888.95
Feb
895.63
Mar
898.66
Apr
887.54
May
890.42
Jun
889.48
Jul
886.17
Aug
885.98
Sep
877.66
Oct
882.18
Nov
876.59
Dec
862.05
2034
872.97
-18.0%
-2.5%
Month
Projected Price (₹)
Jan
868.45
Feb
871.59
Mar
874.68
Apr
882.74
May
894.25
Jun
896.00
Jul
890.83
Aug
894.26
Sep
901.65
Oct
889.87
Nov
876.24
Dec
872.97
2035
863.04
-19.0%
-2.3%
Month
Projected Price (₹)
Jan
865.64
Feb
865.56
Mar
866.42
Apr
865.46
May
866.29
Jun
870.91
Jul
851.68
Aug
842.03
Sep
845.55
Oct
867.09
Nov
867.69
Dec
863.04
2036
906.19
-14.9%
-1.6%
Month
Projected Price (₹)
Jan
858.26
Feb
881.18
Mar
880.23
Apr
872.20
May
888.89
Jun
873.62
Jul
875.15
Aug
880.16
Sep
879.01
Oct
887.26
Nov
904.57
Dec
906.19
Zota Health Care Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
5.6%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
55.2%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹63.92
PredictionsiTotal number of daily predictions made for this stock. More predictions = more data for accuracy metrics. The model self-learns and adjusts its parameters every 7 days, so accuracy typically improves over time.
324
Zota Health Care Ltd – Historical Performance vs Predictions
Zota Health Care Ltd – 3-Month Price Forecast
90-day target: ₹1,008.44|Range: ₹671.32 – ₹1,514.85|By: 07 Aug 2026
Zota Health Care Ltd Tomorrow's Share Price Probability Distribution
Zota Health Care Ltd Share Price Target – Frequently Asked Questions
Will Zota Health Care Ltd share price increase tomorrow?
Zota Health Care Ltd share price is expected to decrease to ₹905.25 on 2026-05-09, which is 15.00% lower than today's price of ₹1,065.00. This prediction is based on our AI-powered GFBM model.
What is the intrinsic value of Zota Health Care Ltd?
Zota Health Care Ltd intrinsic value is ₹140.24, which is 86.83% below the current price of ₹1,065.00. This suggests the stock is currently overvalued.
What is the share price target of Zota Health Care Ltd in 2027?
Zota Health Care Ltd share price target for 2027 is projected to reach ₹1,010.46 by year-end (range: ₹992.67 to ₹1,054.14), representing a -5.12% decrease from the current price of ₹1,065.00.
What is the share price target of Zota Health Care Ltd in 2028?
Zota Health Care Ltd share price target for 2028 is projected to reach ₹974.09 by year-end (range: ₹948.54 to ₹989.85), representing a -8.54% decrease from the current price of ₹1,065.00.
What is the share price target of Zota Health Care Ltd in 2029?
Zota Health Care Ltd share price target for 2029 is projected to reach ₹940.08 by year-end (range: ₹940.08 to ₹976.23), representing a -11.73% decrease from the current price of ₹1,065.00.
Should I buy Zota Health Care Ltd stock now?
Based on current analysis, Zota Health Care Ltd appears to be a consider reviewing your position candidate. Intrinsic value is ₹140.24 vs CMP ₹1,065.00. This is not investment advice — consult a SEBI-registered advisor before making investment decisions.
What is the fundamental floor price for Zota Health Care Ltd?
The fundamental floor price for Zota Health Care Ltd is ₹30.22, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is the theoretical minimum price under normal market conditions.
Zota Health Care Ltd Share Price Prediction – How We Calculate the Targets
We calculate the share price targets for Zota Health Care Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.
Step 1: Calculate the Log Returns
The log returns measure the relative change in stock prices over time. It is calculated as follows:
The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:
\[ H = \frac{\log(R/S)}{\log(n)} \]
Step 6: Project Future Share Prices Using GFBM and EMA
The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.
Step 7: Predicting Tomorrow's Stock Price for Zota Health Care Ltd
The predicted price for tomorrow is derived using the Geometric Brownian Motion (GBM) formula with drift, volatility, and a random factor to simulate market movements.
Step 8: Projected Share Prices for the Next 10 Years
The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.
Conclusion
Our hybrid approach provides a realistic projection of share prices for Zota Health Care Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.
The projected stock prices are provided for informational purposes only and do not constitute investment advice or recommendations. Past performance of securities is not indicative of future results. Getaka Financial Technology is not responsible for any investment decisions made on the basis of this information. Investors are advised to seek independent financial advice from a SEBI-registered investment advisor before making any investment decisions. Investments in the securities market are subject to market risks. Please read all associated offer documents and terms carefully before investing.